美通社

2025-03-28 10:00

Wai Yuen Tong leads the digitalization of traditional Chinese medicine introducing Hong Kong's first smart AI constitution analysis device, pioneers Hong Kong into a new era of healthcare in traditional Chinese medicine

HONG KONG, March 28, 2025 /PRNewswire/ -- Wai Yuen Tong (0897.HK), a pioneer in traditional Chinese medicine in Hong Kong, announced that starting today, five core stores located in Percival Street Causeway Bay, Nathan Road Mong Kok, Cameron Road Tsim Sha Tsui, New Town Plaza Sha Tin, and Telford Plaza Kowloon Bay will initiate a trial introduction of the innovative Smart Traditional Chinese Medicine Health Profiling Device developed by Prevent Medical International Corporation. This marks Wai Yuen Tong's entry into a new era of "AI Diagnosis" in traditional Chinese medicine services. Smart Traditional Chinese Medicine Health Profiling Device digitizes the four diagnostic methods of traditional Chinese medicine: observation, auscultation and olfaction, inquiry, and pulse feeling and palpation. Utilizing cloud-based intelligent algorithms for constitution recognition and integrating the twenty-four solar terms, it assesses customers' traditional Chinese medicine health profiles. This initiative combines Wai Yuen Tong's century-old commitment to pharmacological heritage with innovative technological advancements that enhance the accuracy of traditional diagnosis and treatment, transitioning traditional Chinese healthcare from "empirical medicine" to "data-driven" precision health management, benefiting the new generation living in Hong Kong's fast-paced urban environment.

Diagnosis Integrates Big Data from Four Diagnostic Methods to Greatly Enhance Analytical Accuracy

The Smart Traditional Chinese Medicine Health Profiling Device introduced by Wai Yuen Tong is developed by the Prevent Medical International Corporation, a medical technology research and development platform company focused on creating an AI-driven, full-cycle system for traditional Chinese medicine. The company is dedicated to combining traditional Chinese medicine principles with modern technology to provide accurate and timely diagnosis, treatment, and prevention services in traditional Chinese medicine, empowering the entire smart traditional Chinese medicine landscape. Currently, the core technology of the Smart Traditional Chinese Medicine Health Profiling Device has received multiple certifications, including CCC certification (China Compulsory Certification), software copyright certificates, and national patent certificates for automatic recognition. This has attracted several domestic hospitals, traditional Chinese medicine universities, and wellness platform companies to incorporate the device to assist in diagnosis. To date, the device has reached over 2.4 million users. The Smart Traditional Chinese Medicine Health Profiling Device collects data from face-to-face consultations, tongue examinations, auscultation and olfaction, and inquiry, using cloud-based intelligent algorithms that integrate with the philosophy of the twenty-four solar terms to accurately analyze customers' health profiles.

After introducing the device, Wai Yuen Tong has also upgraded its system by integrating its services. Following the assessment, customers not only receive a personalized comprehensive health profile report but can also implement targeted health improvement suggestions through Wai Yuen Tong's wellness recommendations, allowing them to more effectively select suitable traditional Chinese medicine treatments and supplement products.

In Wai Yuen Tong stores, the Smart Traditional Chinese Medicine Health Profiling Device does not function as an independent technological exhibit; rather, it acts as a 'smart partner' in deep collaboration with registered traditional Chinese medicine practitioners. After the AI completes the data analysis, customers can have their health interpretation results verified by practitioners through pulse diagnosis, ultimately leading to personalized prescriptions. This process leverages the data integration advantages of AI while adhering to the essence of traditional Chinese medicine's diagnostic principles of 'Three Factors Adapting to Circumstances' (considering the individual, the timing, and the location).

Ms. Vivian Tang, Executive Director of Wai Yuen Tong Medicine Holdings Limited said, 'The challenge in traditional Chinese medicine diagnosis lies in the concept of "same disease, different treatment; different diseases, same treatment." AI can quickly screen health profiles, while the practitioner's experience captures the 'human clues' beyond the data. This complementary approach can reduce misdiagnosis rates, significantly enhance patient reassurance, and address the issues of digitalization and standardization in traditional Chinese medicine, improving the efficiency of practitioners' diagnoses and treatments.' With a century-old pharmacy shelf coexisting with smart screens in the consultation rooms, Wai Yuen Tong is innovatively demonstrating that technology is not the opposite of tradition but rather a nourishing element that allows ancient wisdom to take root in contemporary society."

Wai Yuen Tong Constructs a 'Traditional Chinese Medicine Big Health Ecosystem' to Capture the Untapped Market of Preventive Medicine

According to data from the World Health Organization (WHO), better utilization of preventive measures could reduce the global disease burden by up to 70%. In response to the national directive in the '14th Five-Year Plan for National Health' which emphasizes the need to 'implement major projects for the revitalization and development of traditional Chinese medicine and upgrade the health engineering project of "preventing diseases" with traditional Chinese medicine', Wai Yuen Tong is keeping pace with the times. The company has introduced the Smart Traditional Chinese Medicine Health Profiling Device to achieve body constitution analysis and provide intelligent diagnosis results, thereby offering personalized solutions such as traditional Chinese medicine prescriptions and health supplements. At the same time, to deepen the application of preventive medicine, Wai Yuen Tong is currently collaborating with leading AI technology research institutions in the Greater Bay Area. By analyzing and organizing big data from consumers in the Greater Bay Area, the company aims to provide customized health solutions to residents, hoping to reduce the long-term risk of illness and enhance public awareness of the daily applications of traditional Chinese medicine health care. This supports the promotion of the national big health policy.

Embracing New Era Development to Pass Down Millennium-Old Wisdom of Traditional Chinese Medicine Through Technology

In light of rising global health awareness and the trend of digitalization, Wai Yuen Tong will continue to explore the digitalization and modernization of traditional Chinese medicine, striving for a deep integration of traditional culture and innovative technology. The brand plans to further popularize the application of intelligent AI in traditional Chinese medicine through technologies such as AI and big data, making ancient wisdom in diagnosis, health maintenance, and medicinal cuisine more relevant to modern life scenarios. This effort particularly aims to attract the younger generation to understand the scientific and practical value of traditional Chinese medicine.

Ms. Vivian Tang, Executive Director of Wai Yuen Tong Medicine Holdings Limited, emphasized, 'The combination of big data calculations for AI in traditional Chinese medicine and the clinical experience of Wai Yuen Tong's practitioners can further popularize the concept of "preventing diseases." This enables the public to quickly and accurately perceive diseases and adopt preventive treatments, reducing the likelihood of illness or the progression of conditions into actionable lifestyle solutions. Wai Yuen Tong is dedicated to safeguarding public health, providing comprehensive traditional Chinese medicine services and support to every customer, and utilizing technology to ensure the sustainable inheritance of traditional Chinese medicine culture.'"

About Wai Yuen Tong Medicine Holdings Limited

Wai Yuen Tong Medicine Holdings Limited, a listed company on HKEX (Stock Code: 0897), is principally engaged in the production, processing and retailing of pharmaceutical and health products, including five major product categories of Chinese medicine (proprietary Chinese medicines, dietary supplement, homology of medicine and food, decoction and concentrated granule, and lifestyle products) under the brand name of "Wai Yuen Tong", western pharmaceutical, health food and personal care products under the brand names of "Madame Pearl's" and "Pearl's". Wai Yuen Tong has introduced one-stop Chinese medical and healthcare services. For more details, please visit https://www.wyth.net.

source: Wai Yuen Tong Medicine Holdings Limited

【香港好去處】2025去邊最好玩?etnet為你提供全港最齊盛事活動,所有資訊盡在掌握!► 即睇

人氣文章
最近7天
1
關稅戰 | 美媒:美關稅或致中國出口轉向其他國家「如海嘯襲來」
2
港股 | 蕭猷華:關稅貿易戰中,哪國損害最大?
3
關稅戰 | FOCUS | 「恩赦」對象揭盅倒數,中國「奉陪到底」非無因
4
圍堵中國 | FOCUS | 債息逼宮侵侵又眨眼,北京謀周邊外交破局
5
關稅戰 | 中國傾售美債如啟貿易核武  顛覆市場亦可能影響自身
6
高息定存 | 一周高息合集,關稅戰下市況波動,邊間銀行仍有5厘高息?
7
關稅戰 | 中國官方及市場反應
8
美股收盤 | 美股三大指數升逾1.5%,道指彈619點
9
關稅戰 | 美國再加內地及香港小額包裹稅至120%,阿里京東仍獲券商唱好可以點部署?
10
黑色星期一 | 恒指破紀錄單日暴瀉3021點收穿兩萬點,逾六成藍籌雙位數下跌
1
關稅戰 | 美媒:美關稅或致中國出口轉向其他國家「如海嘯襲來」
2
美股收盤 | 美股三大指數收市報升,道指反彈674點
3
高息定存 | 滙豐一周港元定存年息高達10厘,招商永隆推快閃優惠
4
美團上季經調整盈利升逾倍,加大對AI、無人機配送等投入,Keeta沙特用戶訂單迅速增長
5
去中心化交易所RabbitX 不持客戶資產 保障資金安全
6
高息定存 | 一周高息合集,華僑6個月最高3.5厘,恒生7日享10厘
7
美股收盤 | 美股三大指數收市報跌,道指挫715點,納指挫2.7%
8
高息定存 | 一周高息合集,銀行推短存優惠,滙豐一周達10厘,建行亞洲1個月首十萬6.68厘
9
長和系業績 | 長和去年少賺27%遜市場預期,李澤鉅:經營環境難測將限制新投資
10
長和據報下周不會簽出售巴拿馬港口協議,傳分拆環球電訊業務於倫敦上市
11
關稅戰 | David Webb:特朗普對等關稅可笑,如同向美國消費者射入「烏龍球」
12
高息定存 | 建行亞洲3個月特惠年利率5.68厘,大新低門檻3.5厘
13
騰訊業績 | 騰訊全年多賺近七成,縮回購增派息,今年續加大AI投入
14
港股 | 蕭猷華:恒指本周料挑戰25000大關
15
四叔辭世 | 恒地李兆基辭世享年97歲,創立地產王國被封「亞洲股神」,交捧兩子分管中港業務(圖集)
16
恒大 | 恒大汽車午後飆兩倍恒大物業升兩成,同系本港金融業務被曝易名
17
高息定存 | 滙豐3個月特選客3.4厘,工銀98日3.43厘
18
2025年美股市場將更波動    板塊輪動進一步加劇
19
港股 | 蕭猷華:港股短期調整,向上趨勢不變
20
高息定存 | 一周高息合集,星展6個月定存息加至3.25厘,建行亞洲3個月最高5.68厘
21
長和 | FOCUS | 美國挾迫港資,亡羊補牢未遲
22
港股 | 蕭猷華:恒指本周有望反覆上行
23
美股收盤 | 美股三大指數插逾5.5%,千禧年後最慘烈,道指挫2231點
24
騰訊 | 季績勝預期兼增派息,大行齊升目標可趁調整吸納?
25
美股收盤 | 對等關稅震散美股三大指數,道指暴瀉1680點
26
配股潮 | 小米傳折讓配股籌逾400億,張智威料股價最多調整5%,可考慮分階段低吸
27
關稅戰 | FOCUS | 54%對華關稅如掀桌,地緣及供應鏈裂痕難彌
28
小米 | FOCUS | SU7車禍三謎待解,「信任閾值」考驗智駕烏托邦
29
中概動向 | 中概股普遍下跌,納指金龍指數瀉逾8%
30
神州經脈 | 美國再制裁中企,蘋果捐浙大三千萬,A股跌人幣轉升
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

etnet榮膺「第九屆傳媒轉型大獎」四大獎項

【限時優惠$68/月】申請etnet強化版MQ手機串流報價服務 捕捉板塊輪動,提高獲利勝算

請追蹤etnet最新小紅書賬戶@通仔GoGoGo 接收最update情報!

關稅戰

大國博弈

貨幣攻略

說說心理話

Watch Trends 2024

北上食買玩

Art Month 2024

理財秘笈

流感高峰期

山今養生智慧

輕鬆護老